![](/img/cover-not-exists.png)
Ultra Low-Dose IL-2 for GVHD Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation Mediates Expansion of Regulatory T Cells without Diminishing Antiviral and Antileukemic Activity
Kennedy-Nasser, A. A., Ku, S., Castillo-Caro, P., Hazrat, Y., Wu, M.-F., Liu, H., Melenhorst, J., Barrett, A. J., Ito, S., Foster, A., Savoldo, B., Yvon, E., Carrum, G., Ramos, C. A., Krance, R. A., LVolume:
20
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-13-3205
Date:
April, 2014
File:
PDF, 976 KB
english, 2014